Drug Validation Platform

Tailored drug validation strategies are established for monoclonal antibodies, bispecific antibodies, ADCs, antibody fusion proteins and other modalities, meeting the efficacy evaluation needs of diverse antibody formats, helping to identify the potential risks of antibody drugs and to select superior lead molecules. Our expert team brings together clinical physicians, pharmaceutical scientists and R&D scientists with extensive experience in designing in vivo efficacy and safety evaluation programs. In response to each client’s specific needs, we provide more professional and faster study designs and optimization recommendations, effectively addressing complex cases and enabling antibody drug development programs to advance “faster and better”.

Systematic
Tailored